Estrogen and progesterone together expand murine endometrial epithelial progenitor cells

Stem Cells

Volumn 31, Issue 4, 2013, Pages 808-822

  Janzen, Deanna M ^a   Cheng, Donghui ^b   Schafenacker, Amanda M ^a   Paik, Daniel Y ^a   Goldstein, Andrew S ^a,b   Witte, Owen N ^a,b   Jaroszewicz, Artur ^b   Pellegrini, Matteo ^b   Memarzadeh, Sanaz ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Endometrial epithelial progenitors; Estrogen; Paracrine signaling; Progesterone

Indexed keywords

ALPHA6 INTEGRIN; CD31 ANTIGEN; CELL PROTEIN; EPITHELIAL CELL ADHESION MOLECULE; ESTROGEN; ESTROGEN RECEPTOR; HERMES ANTIGEN; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN TYROSINE PHOSPHATASE RECEPTOR C; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; TER119 PROTEIN; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL REGENERATION; CELL SUBPOPULATION; CELL TRANSDIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOMETRIAL EPITHELIAL PROGENITOR CELL; ENDOMETRIUM CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PARACRINE SIGNALING; STEM CELL; STEM CELL EXPANSION; STEM CELL NICHE;

ANIMALS; CELLS, CULTURED; ENDOMETRIUM; EPITHELIAL CELLS; ESTROGENS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; PROGESTERONE; STEM CELLS;

MURINAE;

EID: 84875793050     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1337     Document Type: Article

References (84)

1. Giudice LC. Clinical practice. Endometriosis. N Engl J Med 2010; 362:2389-2398.
2. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
3. Prianishnikov VA. A functional model of the structure of the epithelium of normal, hyperplastic and malignant human endometrium: A review. Gynecol Oncol 1978;6:420-428.
4. Kyo S, Maida Y, Inoue M. Stem cells in endometrium and endometrial cancer: Accumulating evidence and unresolved questions. Cancer Lett 2011;308:123-133.
5. Teixeira J, Rueda BR, Pru JK. Uterine stem cells. In: Stem Book (Internet) Harvard Stem Cell Institute, Cambridge, MA. 2008. Available at http://www.ncbi.nlm.nih.gov/books/NBK27042.
6. Gargett CE, Nguyen HP, Ye L. Endometrial regeneration and endometrial stem/progenitor cells. Rev Endocr Metab Disord 2012;13: 235-251.
7. Chan RW, Gargett CE. Identification of label-retaining cells in mouse endometrium. Stem Cells 2006;24:1529-1538.
8. Chan RW, Kaitu'u-Lino T, Gargett CE. Role of label retaining cells in estrogen-induced endometrial regeneration. Reprod Sci 2011;19: 102-14.
9. Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod 2004;70:1738-1750.
10. Masuda H, Matsuzaki Y, Hiratsu E et al. Stem cell-like properties of the endometrial side population: Implication in endometrial regeneration. PLoS One 2010;5:e10387.
11. Kato K, Yoshimoto M, Adachi S et al. Characterization of side-population cells in human normal endometrium. Hum Reprod 2007;22: 1214-1223.
12. Bratincsak A, Brownstein MJ, Cassiani-Ingoni R et al. CD45-positive blood cells give rise to uterine epithelial cells in mice. Stem Cells 2007;25:2820-2826.
13. Du H, Taylor HS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells 2007;25:2082-2086.
14. McLennan CE, Rydell AH. Extent of endometrial shedding during normal menstruation. Obstet Gynecol 1965;26:605-621.
15. Dharma SJ, Kholkute SD, Nandedkar TD. Apoptosis in endometrium of mouse during estrous cycle. Indian J Exp Biol 2001;39:218-222.
16. Wood GA, Fata JE, Watson KL et al. Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus. Reproduction 2007;133:1035-1044.
17. Memarzadeh S, Zong Y, Janzen DM et al. Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium. Proc Natl Acad Sci USA 2010;107:17298-17303.
18. Hu Y, Smyth GK. ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009;347:70-78.
19. Trapnell C, Pachter L, Salzberg SL. TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 2009;25:1105-1111.
20. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
21. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009;37:1-13.
22. Kuhn RM, Haussler D, Kent WJ. The UCSC genome browser and associated tools. Brief Bioinform 2012 [Epub ahead of print]. doi: 10.1093/bib/bbs038.
23. Gray CA, Bartol FF, Tarleton BJ et al. Developmental biology of uterine glands. Biol Reprod 2001;65:1311-1323.
24. Stewart CA, Fisher SJ, Wang Y et al. Uterine gland formation in mice is a continuous process, requiring the ovary after puberty, but not after parturition. Biol Reprod 2011;85:954-964.
25. Caligioni CS. Assessing reproductive status/stages in mice. Curr Protoc Neurosci 2009;Appendix 4:Appendix 4I.
26. Stingl J, Eirew P, Ricketson I et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006;439:993-997.
27. Shackleton M, Vaillant F, Simpson KJ et al. Generation of a functional mammary gland from a single stem cell. Nature 2006;439:84-88.
28. Martin L, Finn CA, Trinder G. Hypertrophy and hyperplasia in the mouse uterus after oestrogen treatment: An autoradiographic study. J Endocrinol 1973;56:133-144.
29. Whitehead MI, King RJ, McQueen J et al. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy. J R Soc Med 1979;72:322-327.
30. Parr BA, McMahon AP. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 1998;395:707-710.
31. Mericskay M, Kitajewski J, Sassoon D. Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Development 2004; 131:2061-2072.
32. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-1851.
33. He TC, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-1512.
34. Mann B, Gelos M, Siedow A et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999;96:1603-1608.
35. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426.
36. Shtutman M, Zhurinsky J, Simcha I et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-5527.
37. Jho EH, Zhang T, Domon C et al. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002;22:1172-1183.
38. Wielenga VJ, Smits R, Korinek V et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999;154:515-523.
39. Zeilstra J, Joosten SP, Dokter M et al. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. Cancer Res 2008;68:3655-3661.
40. Rockman SP, Currie SA, Ciavarella M et al. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. J Biol Chem 2001;276:45113-45119.
41. Afify AM, Craig S, Paulino AF et al. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Ann Diagn Pathol 2005;9:312-318.
42. Gao Y, Liu T, Cheng W et al. Isolation and characterization of proliferative, migratory and multidrug-resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines. Oncol Rep 2012;28:527-532.
43. Behzad F, Seif MW, Campbell S et al. Expression of two isoforms of CD44 in human endometrium. Biol Reprod 1994;51:739-747.
44. Tesco G, Kim TW, Diehlmann A et al. Abrogation of the presenilin 1/beta-catenin interaction and preservation of the heterodimeric presenilin 1 complex following caspase activation. J Biol Chem 1998;273: 33909-33914.
45. King AE, Critchley HO, Kelly RW. Innate immune defences in the human endometrium. Reprod Biol Endocrinol 2003;1:116.
46. Fahey JV, Schaefer TM, Wira CR. Sex hormone modulation of human uterine epithelial cell immune responses. Integr Comp Biol 2006;46: 1082-1087.
47. Simons BD, Clevers H. Strategies for homeostatic stem cell selfrenewal in adult tissues. Cell 2011;145:851-862.
48. Barker N, van Es JH, Kuipers J et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449: 1003-1007.
49. Schepers AG, Vries R, van den Born M et al. Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomes. EMBO J 2011;30:1104-1109.
50. Gomez DE, Armando RG, Farina HG et al. Telomere structure and telomerase in health and disease (review). Int J Oncol 2012;41: 1561-1569.
51. Zoller M. CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 2011;11:254-267.
52. Bennett KL, Jackson DG, Simon JC et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995;128:687-698.
53. Katagiri YU, Sleeman J, Fujii H et al. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 1999;59: 219-226.
54. Jalkanen S, Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 1992;116: 817-825.
55. Gallatin WM, Wayner EA, Hoffman PA et al. Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc Natl Acad Sci USA 1989;86: 4654-4658.
56. Wayner EA, Carter WG. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol 1987; 105:1873-1884.
57. Ramathal CY, Bagchi IC, Taylor RN et al. Endometrial decidualization: Of mice and men. Semin Reprod Med 2010;28:17-26.
58. Xin L, Lukacs RU, Lawson DA et al. Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 2007;25:2760-2769.
59. Paik DY, Janzen DM, Schafenacker AM et al. Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: A site for injury and serous cancer initiation. Stem Cells 2012;30:2487-2497.
60. Khaldoyanidi S, Denzel A, Zoller M. Requirement for CD44 in proliferation and homing of hematopoietic precursor cells. J Leukoc Biol 1996;60:579-592.
61. Poncelet C, Leblanc M, Walker-Combrouze F et al. Expression of cadherins and CD44 isoforms in human endometrium and peritoneal endometriosis. Acta Obstet Gynecol Scand 2002;81:195-203.
62. Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009;23:2563-2577.
63. Visvader JE, Smith GH. Murine mammary epithelial stem cells: Discovery, function, and current status. Cold Spring Harb Perspect Biol 2011; 3.
64. Goldstein AS, Huang J, Guo C et al. Identification of a cell of origin for human prostate cancer. Science 2010;329:568-571.
65. Goldstein AS, Lawson DA, Cheng D et al. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci USA 2008;105:20882-20887.
66. Choi N, Zhang B, Zhang L et al. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 2012;21:253-265.
67. Masuda H, Anwar SS, Buhring HJ et al. A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplant 2012;21: 2201-2214.
68. Spitzer TL, Rojas A, Zelenko Z et al. Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype. Biol Reprod 2012;86:58.
69. Wang Y, Sacchetti A, van Dijk MR et al. Identification of quiescent, stem-like cells in the distal female reproductive tract. PLoS One 2012; 7:e40691.
70. Cervello I, Martinez-Conejero JA, Horcajadas JA et al. Identification, characterization and co-localization of label-retaining cell population in mouse endometrium with typical undifferentiated markers. Hum Reprod 2007;22:45-51.
71. Schwab KE, Chan RW, Gargett CE. Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle. Fertil Steril 2005;84(Suppl 2):1124-1130.
72. Asselin-Labat ML, Vaillant F, Sheridan JM et al. Control of mammary stem cell function by steroid hormone signalling. Nature 2010; 465:798-802.
73. Joshi PA, Jackson HW, Beristain AG et al. Progesterone induces adult mammary stem cell expansion. Nature 2010;465:803-807.
74. Kiel MJ, He S, Ashkenazi R et al. Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU. Nature 2007; 449:238-242.
75. Kaitu'u-Lino TJ, Ye L, Salamonsen LA et al. Identification of labelretaining perivascular cells in a mouse model of endometrial decidualization, breakdown, and repair. Biol Reprod 2012;86:184.
76. Szotek PP, Chang HL, Zhang L et al. Adult mouse myometrial labelretaining cells divide in response to gonadotropin stimulation. Stem Cells 2007;25:1317-1325.
77. Wang X, Kruithof-de Julio M, Economides KD et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009;461:495-500.
78. Van Keymeulen A, Rocha AS, Ousset M et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011;479:189-193.
79. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
80. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1996;275:370-375.
81. Conneely OM, Mulac-Jericevic B, DeMayo F et al. Reproductive functions of progesterone receptors. Recent Prog Horm Res 2002;57: 339-355.
82. Al-Sabbagh M, Lam EW, Brosens JJ. Mechanisms of endometrial progesterone resistance. Mol Cell Endocrinol 2012;358:208-215.
83. Winuthayanon W, Hewitt SC, Orvis GD et al. Uterine epithelial estrogen receptor alpha is dispensable for proliferation but essential for complete biological and biochemical responses. Proc Natl Acad Sci USA 2010;107:19272-19277.
84. Li Q, Kannan A, DeMayo FJ et al. The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2. Science 2011; 331:912-916.